Skip to main content

Healthy Adult Females

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
1
GSK1349572Phase 1
Bioiberica
BioibericaSpain - Barcelona
1 program
DERMIALN/A1 trial
Active Trials
NCT07790237Active Not Recruiting146Est. Mar 2028
GSK
GSKLONDON, United Kingdom
1 program
GSK1349572PHASE_11 trial
Active Trials
NCT01404806Completed10Est. Sep 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
GSKGSK1349572
BioibericaDERMIAL

Clinical Trials (2)

Total enrollment: 156 patients across 2 trials

NCT01404806GSKGSK1349572

GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue in Healthy Female Subjects

Start: Aug 2011Est. completion: Sep 201210 patients
Phase 1Completed

Clinical Study to Evaluate the Anti-aging Efficacy and Skin Radiance-enhancing Effect of Dermial®.

Start: Jul 2026Est. completion: Mar 2028146 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.